Captor Therapeutics Spolka Akcyjna
CTX.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 197 | PLN 465 | PLN 667 | PLN 742 |
| - Cash | PLN 39 | PLN 76 | PLN 71 | PLN 118 |
| + Debt | PLN 6 | PLN 4 | PLN 7 | PLN 8 |
| Enterprise Value | PLN 163 | PLN 393 | PLN 603 | PLN 632 |
| Revenue | PLN 16 | PLN 13 | PLN 9 | PLN 4 |
| % Growth | 19.9% | 44.1% | 129.8% | – |
| Gross Profit | PLN 6 | PLN 7 | PLN 7 | PLN 3 |
| % Margin | 40.6% | 52.3% | 77.2% | 81.4% |
| EBITDA | -PLN 33 | -PLN 65 | -PLN 28 | -PLN 24 |
| % Margin | -208.1% | -490.6% | -308.2% | -612.4% |
| Net Income | -PLN 38 | -PLN 71 | -PLN 36 | -PLN 33 |
| % Margin | -242.8% | -534.7% | -391.9% | -817.2% |
| EPS Diluted | -8.25 | -15.19 | -8.61 | -7.89 |
| % Growth | 45.7% | -76.4% | -9.1% | – |
| Operating Cash Flow | -PLN 32 | -PLN 52 | -PLN 23 | -PLN 28 |
| Capital Expenditures | -PLN 0 | -PLN 3 | -PLN 1 | -PLN 5 |
| Free Cash Flow | -PLN 32 | -PLN 55 | -PLN 24 | -PLN 34 |